Prodrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity is a research paper published in International Journal of Molecular Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health National Cancer Institute
Grant: R01CA262084
National Institutes of Health National Cancer Institute
Grant: 3U01FD005946
National Institutes of Health National Cancer Institute
Grant: U01FD008322
FDA HHS
Grant: U01 FD005946
NCI NIH HHS
Grant: CA262084
National Institutes of Health
Grant: 1U01FD008322-01
Comprehensive assessment of the diastereomer composition of LEQVIO (Inclisiran) to determine how chemical synthesis impacts biological activity
National Institutes of Health
Grant: 3U01FD005946-07S3
University of Maryland Center of Excellence in Regulatory Science and Innovation
National Institutes of Health
Grant: 1R01CA262084-01
Novel noncanonical actions of CAR in human Liver
MeSH Terms
Keywords